Avid Bioservices Inc (CDMO)

[sulaco]

Sunstar, alway appreciate your solid cancer
lists that are in play for Bavi's MOA. The potential is clearly vast if we can potentiate and synergize with the other anti-XYZ and T-cell players.

The big BPs have already poured billions into their T-cell modulators and they want ROI. unfortunately for them, large groups of non-responders are emerging. Side effects are also a problem as T-cells get overstimulated and provoke auto-immunity.

If Bavi can get non-responders to responds, and smooth over some of these others Mabs side effects, then hold on tight.

To quote Warren Buffet: "Buy and hold...forever."


Regards,

Joe